| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Business EPS guidance reiterated Sanofi expects 2024 business EPS(1) to remain roughly stable excluding the impact of an expec...
Sanofi (NASDAQ:SNY) reported quarterly earnings of $0.97 per share which beat the analyst consensus estimate of $0.94 by 2.77 p...
We will now drive the Company based on a revised plan for FY24 revenues in the range of $14 billion to $15 billion. Within th...
In a recent interview, billionaire investor Howard Marks cautioned against overconfidence in Artificial Intelligence (AI) stock...
Business Outlook ST's guidance, at the mid-point, for the 2024 second quarter is: Net revenues are expected to be $3.2 ...
In this second tranche of the share buy-back programme for 2024, shares for up to USD 528 million will be purchased in the mark...
OpenAI CEO Sam Altman has invested $20 million in Exowatt, an energy startup aiming to address the soaring electricity demands ...
STMicroelectronics (NYSE:STM) reported quarterly earnings of $0.54 per share which missed the analyst consensus estimate of $0....
Equinor (NYSE:EQNR) reported quarterly earnings of $0.96 per share which beat the analyst consensus estimate of $0.80 by 20 per...
